Alphatec Holdings Inc

Alphatec Holdings Inc

ATEC · NASDAQ · Healthcare / Medical Devices

7.07USD+0.01 (+0.14%)

Price History

Full chart

Market Stats

Previous Close7.06
Open7.13
Day Range7.05 – 7.26
52-Week Range6.82 – 23.29
Volume3.53M
Market Cap1.56B
P/E (TTM)0.00
Forward P/E18.55
EPS-0.71
Dividend Yield0.00%
Beta0.85
50-Day Avg9.48
200-Day Avg11.83

About

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Patrick S. Miles
  • Employees913
  • Headquarters1950 Camino Vida Roble, Carlsbad, CA, United States, 92008, USA
  • Websitehttps://www.atecspine.com

Leadership

  • Mr. Patrick S. MilesChairman, CEO & President · b. 1966
  • Mr. J. Todd KoningExecutive VP & CFO · b. 1973
  • Mr. Scott LishChief Operating Officer · b. 1981
  • Mr. David P. SponselExecutive Vice President of Sales · b. 1979
  • Mr. Craig E. HunsakerExecutive Vice President of People & Culture · b. 1964
  • Mr. Robert JuddVP of Finance and Investor Relations & Controller
  • Mr. Tyson Eliot MarshallGeneral Counsel & Corporate Secretary · b. 1974
  • Mr. Ali ShorooghiSenior Vice President of Marketing · b. 1986
  • Mr. Jonathan AllenExecutive Vice President of Commercial Operations · b. 1960
  • Dr. Luiz Pimenta M.D., Ph.D.Chief Medical Officer

Financials

Income Statement

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue13.96M11.34M10.89M17.82M42.33M74.00M80.03M101.31M132.16M171.61M197.71M196.28M204.72M206.98M185.28M120.25M101.74M91.69M113.43M144.86M243.21M350.87M482.26M611.56M764.15M
Growth (%)--18.80%-3.94%+63.64%+137.50%+74.85%+8.14%+26.59%+30.44%+29.85%+15.21%-0.72%+4.30%+1.10%-10.48%-35.10%-15.39%-9.87%+23.70%+27.71%+67.89%+44.26%+37.45%+26.81%+24.95%
Cost of Revenue5.85M4.50M-5.46M17.72M25.70M29.82M36.60M48.02M58.79M80.78M70.76M78.67M61.83M63.74M44.11M39.41M28.46M35.83M42.36M85.45M117.81M172.06M187.30M232.27M
Gross Profit8.12M6.84M10.89M12.36M24.60M48.30M50.21M64.71M84.14M112.82M116.93M125.52M126.06M145.15M121.54M76.13M62.33M63.24M77.59M102.50M157.76M233.06M310.20M424.26M531.89M
Gross Margin58.13%60.32%100.00%69.36%58.13%65.27%62.73%63.87%63.67%65.74%59.14%63.95%61.57%70.13%65.60%63.31%61.27%68.97%68.41%70.76%64.87%66.42%64.32%69.37%69.60%
Operating Expense7.84M7.64M012.18M39.65M70.42M69.89M92.51M93.70M124.61M141.45M135.35M199.49M143.30M293.98M91.51M71.34M85.68M124.87M161.36M285.82M380.03M483.60M560.43M614.02M
Operating Income277.21K-798.00K10.89M177.81K-15.04M-22.11M-19.69M-27.81M-9.56M-11.79M-24.52M-9.84M-73.43M1.84M-172.44M-15.38M-9.00M-22.44M-47.28M-58.86M-128.06M-146.97M-173.40M-136.17M-82.13M
Operating Margin1.99%-7.04%100.00%1.00%-35.54%-29.88%-24.60%-27.45%-7.23%-6.87%-12.40%-5.01%-35.87%0.89%-93.07%-12.79%-8.85%-24.47%-41.68%-40.63%-52.65%-41.89%-35.95%-22.27%-10.75%
EBITDA277.21K-798.00K10.89M1.55M-11.50M-13.10M-8.27M-18.21M2.38M6.71M-3.79M10.38M-48.81M20.21M-149.37M-13.20M136.00K-13.21M-38.77M-54.84M-106.88M-102.58M-110.59M-53.87M-39.70M
EBITDA Margin1.99%-7.04%100.00%8.70%-27.18%-17.70%-10.34%-17.98%1.80%3.91%-1.91%5.29%-23.84%9.76%-80.62%-10.98%0.13%-14.40%-34.18%-37.86%-43.95%-29.24%-22.93%-8.81%-5.20%
Net Income91.88K-1.04M-833.50K509.45K-14.05M-25.82M-20.20M-29.29M-13.29M-14.36M-22.18M-15.46M-82.23M-12.88M-178.68M-30.32M-2.29M-28.98M-57.00M-78.99M-143.03M-151.29M-186.64M-162.12M-143.36M
Net Income Margin0.66%-9.19%-7.65%2.86%-33.20%-34.88%-25.24%-28.91%-10.06%-8.36%-11.22%-7.88%-40.16%-6.22%-96.44%-25.21%-2.25%-31.60%-50.25%-54.53%-58.81%-43.12%-38.70%-26.51%-18.76%
R&D326.15K415.00K-1.18M4.07M3.59M6.36M12.96M13.49M19.40M16.89M15.23M14.19M17.33M18.04M9.25M4.92M9.98M13.85M18.75M32.02M44.03M70.11M80.72M76.27M
R&D as % of Total Revenue2.34%3.66%-6.60%9.61%4.85%7.95%12.80%10.21%11.30%8.54%7.76%6.93%8.37%9.74%7.69%4.84%10.89%12.21%12.94%13.16%12.55%14.54%13.20%9.98%
Interest Expense0240.00K0311.51K1.93M2.13M868.00K1.88M3.49M4.70M3.03M6.11M3.96M3.02M4.00M5.37M7.62M7.14M27.18M12.37M7.11M5.50M16.64M24.88M21.14M
Interest Expense % of Total Revenue0.00%2.12%0.00%1.75%4.56%2.88%1.08%1.85%2.64%2.74%1.53%3.11%1.93%1.46%2.16%4.46%7.48%7.79%23.97%8.54%2.92%1.57%3.45%4.07%2.77%

Balance Sheet

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets9.21M7.08M-11.31M109.14M129.28M147.24M155.55M161.89M377.02M366.69M382.13M365.63M344.92M146.70M94.19M84.66M129.48M169.95M261.22M572.05M520.97M805.21M775.71M791.21M
Total Liabilities6.16M5.04M-9.48M126.48M51.56M52.39M84.08M87.06M110.58M121.36M136.31M193.95M195.97M183.28M136.08M111.32M111.90M126.32M131.34M492.63M555.63M703.49M766.28M755.18M
Total Equity3.05M2.04M-1.83M-19.26M75.00M94.85M71.47M74.83M266.43M245.33M245.82M171.68M148.95M-36.58M-41.90M-26.66M17.57M43.63M129.88M79.42M-34.67M101.72M9.43M36.03M
Cash977.31K1.12M-1.56M2.18M16.94M25.84M18.32M10.09M23.17M20.67M22.24M21.34M19.73M11.23M19.59M22.47M29.05M47.11M107.77M187.25M84.70M220.97M138.84M160.81M
Total Debt-1.31M-5.54M9.43M8.33M6.71M2.11M6.72M1.71M28.20M1.70M54.90M82.67M80.11M46.20M41.07M45.58M55.25M43.12M331.04M395.86M541.68M609.94M619.95M
Net Debt-977.31K187.00K-3.99M7.25M-8.61M-19.13M-16.21M-3.36M-21.46M-16.27M-20.54M-16.42M-11.66M68.88M-16.48M18.61M-25.78M-45.31M-102.68M-182.69M311.17M320.71M471.10M459.14M

Cash Flow

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.28M-8.24M-8.59M-13.24M-19.48M-5.55M-14.83M13.41M11.59M7.81M-20.27M10.12M-9.96M-8.73M-25.61M-33.12M-46.41M-73.43M-75.13M-78.48M-44.65M45.23M
Investing Cash Flow-598.47K-80.99M-10.75M-8.94M-9.14M-12.73M-14.41M-9.52M-19.40M-19.10M-11.00M-12.25M61.96M-6.50M-21.67M-13.03M-23.86M-157.76M-58.28M-141.97M-93.14M-53.41M
Financing Cash Flow109.96K90.99M33.77M31.32M21.41M10.27M43.06M-6.92M8.48M10.69M30.73M-6.53M-43.39M17.82M53.88M64.18M130.83M311.97M31.23M356.92M56.21M30.02M
Capital Expenditure598.47K4.26M9.70M7.98M13.39M13.18M16.33M8.90M17.40M15.10M11.30M12.25M9.15M7.60M6.91M13.03M23.89M68.54M58.28M86.97M93.14M42.45M
Free Cash Flow683.31K-12.50M-18.30M-21.22M-32.87M-18.72M-31.16M4.51M-5.80M-7.29M-31.57M-2.12M-19.11M-16.32M-32.52M-46.15M-70.30M-141.98M-133.41M-165.46M-137.79M2.78M
Dividends Paid-------0000000---316.25M3.04M1.06M--
FCF to OCF53.31%151.68%212.91%160.32%168.75%337.49%210.08%33.65%-50.06%-93.44%155.74%-20.97%191.85%187.02%127.00%139.35%151.47%193.34%177.57%210.82%308.59%6.14%
Dividend Paid to FCF-------0.00%0.00%0.00%0.00%0.00%0.00%0.00%----222.75%-2.28%-0.64%--

Earnings

Report DateJul 27, 2006Nov 7, 2006Feb 22, 2007Apr 26, 2007Aug 6, 2007Oct 23, 2007Feb 13, 2008Apr 24, 2008Aug 4, 2008Nov 3, 2008Mar 2, 2009May 4, 2009Aug 3, 2009Nov 9, 2009Feb 23, 2010May 10, 2010Aug 5, 2010Nov 8, 2010Feb 24, 2011May 4, 2011Aug 4, 2011Nov 1, 2011Feb 28, 2012May 8, 2012Aug 7, 2012Nov 5, 2012Feb 28, 2013Apr 30, 2013Aug 6, 2013Nov 7, 2013Mar 17, 2014Apr 30, 2014Jul 31, 2014Oct 30, 2014Feb 26, 2015Apr 30, 2015Aug 4, 2015Nov 3, 2015Mar 15, 2016May 6, 2016Aug 9, 2016Nov 9, 2016Mar 15, 2017May 11, 2017Aug 10, 2017Nov 9, 2017Mar 8, 2018May 10, 2018Aug 2, 2018Nov 8, 2018Mar 7, 2019May 9, 2019Jul 24, 2019Oct 30, 2019Mar 5, 2020May 11, 2020Aug 6, 2020Nov 5, 2020Mar 4, 2021May 6, 2021Aug 3, 2021Nov 4, 2021Mar 1, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Feb 28, 2023May 4, 2023Aug 3, 2023Nov 6, 2023Feb 27, 2024May 7, 2024Jul 31, 2024Oct 30, 2024Feb 25, 2025May 1, 2025Jul 31, 2025Oct 30, 2025Feb 24, 2026May 5, 2026Aug 4, 2026Oct 29, 2026
EPS Estimate-1.68-1.14-1.71-0.84-0.67-0.58-1.42-1.12-0.55-0.77-1.00-0.56-0.52-0.12-0.12-0.180.18-0.19-0.11-0.060.020.09--0.12-0.10-0.16-0.15-0.04-0.36-0.20-0.20-0.24-0.24-0.08-0.12-0.18-0.24-0.48-0.36-0.48-----0.15-0.34-0.24-0.41-0.12-0.18-0.16-0.21-0.27-0.22-0.19-0.21-0.28-0.16-0.21-0.20-0.21-0.20-0.31-0.21-0.17-0.17-0.28-0.16-0.12-0.08-0.25-0.14-0.12-0.11-0.04-0.12-0.04-0.020.04-0.00-0.12-0.07
EPS Actual-2.40-1.56-4.08-0.96-0.24-0.60-2.88-0.84-0.96-1.20-1.32-1.08-0.48-0.240.12-1.08-0.12-0.04-0.24-0.25-0.24-0.18-0.72-0.17-0.12-0.12-0.60-0.18-0.12-0.24-1.320.12-0.24-0.12-0.36-0.36-0.360.60-0.36-0.48-0.62-0.74-1.07-0.61-0.24-0.220.53-0.24-0.21-0.22-0.25-0.29-0.24-0.25-0.28-0.19-0.20-0.19-0.35-0.19-0.29-0.27-0.40-0.20-0.17-0.15-0.33-0.18-0.12-0.11-0.37-0.16-0.14-0.13-0.06-0.090.020.030.06-0.22-0.16-
Surprise-42.86%-36.84%-138.60%-14.29%64.18%-3.45%-102.82%25.00%-74.55%-55.84%-32.00%-92.86%7.69%-100.00%200.00%-500.00%-166.67%78.95%-118.18%-321.00%-1300.00%-295.78%--41.75%-20.00%25.00%-300.00%-350.00%66.67%-20.00%-560.00%150.00%0.00%-50.00%-200.00%-100.00%-50.00%225.00%0.00%0.00%-----60.00%35.29%320.83%41.46%-75.00%-22.22%-56.25%-38.10%11.11%-13.64%-47.37%9.52%28.57%-18.75%-66.67%5.00%-38.10%-35.00%-29.03%4.76%0.00%11.76%-17.86%-12.50%0.00%-37.50%-48.00%-14.29%-16.67%-18.18%-70.13%25.00%150.00%250.00%60.00%-6013.89%-33.33%-
TimingPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.56B
Enterprise Value2.03B
Trailing P/E0.00
Forward P/E18.55
PEG Ratio0.48
Price / Sales1.92
Price / Book126.55
EPS-0.71
Book Value-0.079
Revenue (TTM)815.05M
Gross Profit (TTM)577.36M
EBITDA38.36M
Profit Margin-13.50%
Operating Margin-0.93%
Return on Equity-373.44%
Return on Assets-3.07%
Shares Outstanding153.79M
Shares Float122.06M
Beta0.85
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 10 analystsTarget 15.79
  • Strong Buy
    4
  • Buy
    5
  • Hold
    1

Ownership Breakdown

Institutions
76.46%
Insiders
20.46%
Retail / Other
3.08%

Top Institutional Holders

  • BlackRock Inc
    10.09M6.53%
  • American Century Companies Inc
    6.52M4.22%
  • Vanguard Capital Management, LLC
    4.91M3.18%
  • Royal Bank of Canada
    4.52M2.92%
  • BNP Paribas Investment Partners SA
    3.62M2.34%
  • State Street Corp
    3.03M1.96%
  • Geode Capital Management, LLC
    2.91M1.88%
  • Nuveen, LLC
    2.85M1.84%
  • Tremblant Capital Group
    2.58M1.67%
  • Bank of America Corp
    2.56M1.66%
  • Point72 Asset Management, L.P.
    2.49M1.61%
  • Citadel Advisors Llc
    2.46M1.59%
  • Hood River Capital Management LLC
    2.30M1.49%
  • BRAIDWELL LP
    2.17M1.41%
  • Emerald Advisers, LLC
    2.10M1.36%
  • Arnhold & S. Bleichroeder Advisers, LLC
    1.99M1.29%

Top Fund Holders

  • American Century Small Cap Growth Inv
    4.90M3.17%
  • Vanguard MStar Total Stk Mkt Idx Invest
    3.65M2.36%
  • iShares Russell 2000 ETF
    3.18M2.06%
  • Vanguard Mid Cap Growth Inv
    2.21M1.43%

Stock Splits

  • Aug 25, 20161:12